previous compound ID: 2357 next compound
InChIKey: VNFPBHJOKIVQEB-UHFFFAOYSA-N
SMILES: C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "J Goepp" "E Matthes" "GW Carlile" "JW Hanrahan" "SD Macknight" "R Robert" "J Liao" "D Rotin" "DY Thomas"

chemical graph of compound 2357





CID is 2812
synonyms found at PubChem are:
clotrimazole, 23593-75-1, Lotrimin, Canesten, Mycelex, Mycosporin, Empecid, Clotrimazol, Mykosporin, Gyne lotrimin, Chlotrimazole, Trimysten, 1-(o-Chlorotrityl)imidazole, Mycelex G, Rimazole, Mycelex 7, Tibatin, Mono-baycuten, Lotrimin AF Cream, Mycelex Troches, Gyne-Lotrimin, Lotrimin AF Solution, Mycelex OTC, Canestine, Pedisafe, Veltrim, Gynix, Lotrimin Af, Trivagizole 3, Desamix F, Mycelex-G, Fem Care, Gyne-Lotrimin 3, Mycelex-7, Clotrimazolum, Monobaycuten, (Chlorotrityl)imidazole, Canifug, BAY b 5097, 1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole, Lotrimax, Lotrimin AF Jock-Itch Cream, Mycelax, Mycofug, Mycelex-7 Combination Pack, BAY 5097, Gyne-Lotrimin Combination Pack, Clotrimaderm, Klotrimazole, 1-(o-Chloro-alpha,alpha-diphenylbenzyl)imidazole, Canestene, Clomatin, Cutistad, Esparol, Kanesten, Stiemazol, Nalbix, Gyne-Lotrimin 3 Combination Pack, FemCare, Lotrimin Lotion, Canesten Cream, Gino-Lotremine, Lotrimin Cream, Mycelex Cream, Myclo Solution, Mycelex Solution, Myclo Cream, Myclo-Gyne, Pan-Fungex, Bay-B 5097, Canesten Solution, Lotrimin Solution, Neo-Zol Cream, Mycelex Twin Pack, Lotrimin (TN), Lotrimin AF Lotion, Mycelex (TN), Clotrimazol [INN-Spanish], Clotrimazolum [INN-Latin], 1-(o-Chlorophenyldiphenylmethyl)imidazole, Myclo Spray Solution, clotrimeizol, (2-Chlorophenyl)diphenyl-1-imidazolylmethane, Cimitidine, Diphenyl(2-chlorophenyl)(1-imidazolyl)methane, Diphenyl-(2-chlorophenyl)-1-imidazolylmethane, 1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole, NSC 257473, Canesten 1-Day Therapy, Canesten 3-Day Therapy, Canesten 6-Day Therapy, FB 5097, 1H-Imidazole, 1-[(2-chlorophenyl)diphenylmethyl]-, Mycelex: MycosporinRimazole, DRG-0072, Bay b 9057, C22H17ClN2, Prestwick_120, B 5097, UNII-G07GZ97H65, Bis-phenyl-(2-chlorophenyl)(1-imidazoyl)methane, CCRIS 6245, Canesten 1-Day Cream Combi-Pak, Methane, bis-phenyl-(2-chlorophenyl)-1-imidazolyl-, HSDB 3266, Canesten Combi-Pak 1-Day Therapy, Canesten Combi-Pak 3-Day Therapy, FB b 5097, Bisphenyl-(2-chlorphenyl)-1-imidazolyl-methan, Clotrimazole [USAN:INN:BAN:JAN], EINECS 245-764-8, Lopac-C-6019, NSC257473, 1-[(2-Chlorophenyl)diphenylmethyl]-1H-imidazole, CHEMBL104, 1-[(2-chlorophenyl)(diphenyl)methyl]-1H-imidazole, 1H-Imidazole, 1-((2-chlorophenyl)diphenylmethyl)-, BRN 0622318, GNF-Pf-3499, MLS000028502, CHEBI:3764, 1-((o-Chloro-phenyl)diphenylmethyl)imidazole, 1-[(2-chlorophenyl)-diphenylmethyl]imidazole, Bis-fenil-(2-clorofenil)-1-imidazolil-metano, 1-[(2-chlorophenyl)-diphenyl-methyl]imidazole, VNFPBHJOKIVQEB-UHFFFAOYSA-N, G07GZ97H65, Bis-fenil-(2-clorofenil)-1-imidazolil-metano [Italian], Bisphenyl-(2-chlorphenyl)-1-imidazolyl-methan [German], NCGC00015251-02, CPD000058306, SMR000058306, CAS-23593-75-1, DSSTox_CID_9871, C 6019, Bis-phenyl-(2-chlorophenyl)-1-imidazoyl)methane, DSSTox_RID_78827, DSSTox_GSID_29871, CLT, Imidazole, 1-(o-chloro-alpha,alpha-diphenylbenzyl)-, 1-(o-Chloro-.alpha.,.alpha.-diphenylbenzyl)imidazole, Jidesheng, SR-01000075771, chlortrimazole, clortrimazole, locasten, Otomax, Gyne-Lotrimin3, Clotrimaderm Cream, Clotrimazole,(S), Candinil (TN), Canesten (TN), Clobrate VT (TN), Cancap-VT (TN), Lotrimin AF, Mycelex, Clotrimazole(Canesten), Candid Vaginal (TN), clotrimazole crystalline, Clotrimazole [USAN:USP:INN:BAN:JAN], Spectrum_001343, Clotrimazole (Canesten), AC1L1EIW, Prestwick0_000267, Prestwick1_000267, Prestwick2_000267, Prestwick3_000267, Spectrum2_000128, Spectrum3_000359, Spectrum4_000295, Spectrum5_000781, Candid - V Gel (TN), Clotrimazole Schering Brand, D09GOS, NCIMech_000609, cid_2812, SCHEMBL3850, 1-(2-chlorotrityl)imidazole, BIDD:PXR0036, Lopac0_000315, BSPBio_000114, BSPBio_002057, KBioGR_000850, KBioSS_001823, 5-23-04-00291 (Beilstein Handbook Reference), MLS000758243, MLS001423972, BIDD:GT0450, DivK1c_000665, SPECTRUM1500200, BAY b5097, BAYb 5097, Schering Brand of Clotrimazole, SPBio_000176, SPBio_002333, Bayer Brand 1 of Clotrimazole, Bayer Brand 2 of Clotrimazole, BPBio1_000126, GTPL2330, component of Otomax (Salt/Mix), DTXSID7029871, Gyne-Lotrimin3 Combination Pack, BDBM31774, Clotrimazole (JP15/USP/INN), Clotrimazole (JP17/USP/INN), HMS502B07, KBio1_000665, KBio2_001823, KBio2_004391, KBio2_006959, KBio3_001277, KS-00000XNX, Imidazole, 1-(o-chloro-.alpha.,.alpha.-diphenylbenzyl)-, component of Lotrimax (Salt/Mix), MolPort-002-557-756, NINDS_000665, HMS1568F16, HMS1920O21, HMS2051E11, HMS2091G10, HMS2095F16, HMS2235E20, HMS3260P12, HMS3369I03, HMS3393E11, HMS3655I09, HMS3712F16, Pharmakon1600-01500200, Imidazole,.alpha.-diphenylbenzyl)-, BAY-5097, BCP02150, ZINC3807804, Tox21_110111, Tox21_300415, Tox21_500315, AC-279, CCG-35563, MFCD00057220, NSC756700, s1606, STK700023, AKOS005607024, Tox21_110111_1, AN-5543, API0002086, CS-1926, DB00257, LP00315, MCULE-6862012558, NC00035, NSC-257473, NSC-756700, IDI1_000665, MRF-0000070, QTL1_000024, NCGC00015251-01, NCGC00015251-03, NCGC00015251-04, NCGC00015251-05, NCGC00015251-06, NCGC00015251-07, NCGC00015251-08, NCGC00015251-09, NCGC00015251-10, NCGC00015251-11, NCGC00015251-13, NCGC00015251-14, NCGC00093761-01, NCGC00093761-02, NCGC00093761-03, NCGC00093761-04, NCGC00093761-05, NCGC00093761-06, NCGC00254538-01, NCGC00261000-01, [(2-chlorophenyl)diphenylmethyl]imidazole, 1-(o-chloro-a,a-diphenylbenzyl)imidazole, AS-13816, BC204099, HY-10882, LS-78271, N713, SAM001247056, SC-17936, 1-(2-Chloro-?,?-diphenylbenzyl)imidazole, SBI-0050303.P004, AB0015989, AB1009401, 1-[(2-Chlorophenyl)diphenylmethyl]imidazole, 455-EP2272972A1, 455-EP2272973A1, 455-EP2275420A1, 455-EP2277872A1, 455-EP2281816A1, 455-EP2292595A1, 455-EP2295055A2, 455-EP2295416A2, 455-EP2298748A2, 455-EP2298764A1, 455-EP2298765A1, 455-EP2305642A2, 455-EP2311453A1, 455-EP2311808A1, 455-EP2311829A1, AB00051951, EU-0100315, FT-0603193, ST50994242, C06922, D00282, J10369, 1-(.alpha.-(2-Chlorophenyl)benzhydryl)imidazole, 1-[(2-chlorophenyl)-di(phenyl)methyl]imidazole, AB00051951-14, AB00051951_15, AB00051951_16, Clotrimazole, VETRANAL(TM), analytical standard, 593C751, A816789, 1H-Imidazole, 1-[(2-chlorophenyl)-diphenylmethyl], I01-3474, SR-01000075771-1, SR-01000075771-6, SR-01000075771-8, W-107394, 1-[(2-Chloro-phenyl)-diphenyl-methyl]-1H-imidazole, BRD-K15916496-001-14-7, SR-01000075771-10, 1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole (9CI), 3ACDFDF8-38E3-4368-85D0-BDF8AE1E6591, Clotrimazole, European Pharmacopoeia (EP) Reference Standard, Clotrimazole, United States Pharmacopeia (USP) Reference Standard, Clotrimazole for peak identification, European Pharmacopoeia (EP) Reference Standard, Clotrimazole, Pharmaceutical Secondary Standard; Certified Reference Material, 1-(o-Chloro-|A,|A-diphenylbenzyl)imidazole; 1-(o-Chlorotrityl)imidazole; 1-[(2-Chlorophenyl)diphenylmethyl]-1H-imidazole, 117829-71-7